Expanding the Family Tree
While Chapter 1 provided an introduction to cannabinoids, this chapter delves into the specific types and subcategories, highlighting their unique properties and potential applications. The cannabinoid family is vast, comprising acidic forms, neutral cannabinoids, and even synthetic variations.
Major Cannabinoids
These are the most abundant and researched cannabinoids:
- THC (Delta-9-tetrahydrocannabinol):
- Primary psychoactive compound.
- Known for pain relief, appetite stimulation, and relaxation.
- CBD (Cannabidiol):
- Non-psychoactive.
- Popular for anxiety relief, anti-inflammatory effects, and neuroprotection.
Minor Cannabinoids
Though less abundant, minor cannabinoids offer specialized therapeutic potential:
- CBG (Cannabigerol): The “mother cannabinoid” from which others are derived, offering antibacterial and anti-inflammatory benefits.
- CBN (Cannabinol): Derived from aged THC, known for its sedative effects.
- CBC (Cannabichromene): May support mood regulation and pain relief.
- THCV (Tetrahydrocannabivarin): Offers appetite suppression and energy regulation.
Cannabinoid Acids
Before cannabinoids are activated by heat, they exist in their raw acidic forms, which have unique therapeutic benefits:
- THCA (Tetrahydrocannabinolic Acid): Non-psychoactive and anti-inflammatory.
- CBDA (Cannabidiolic Acid): Shows potential in reducing nausea and anxiety.
- CBGA (Cannabigerolic Acid): The precursor to all other cannabinoid acids.
Synthetic Cannabinoids
These lab-created compounds mimic natural cannabinoids and are used in:
- Pharmaceutical applications, such as dronabinol for nausea.
- Research to explore cannabinoid functions.
- However, some synthetic cannabinoids are linked to adverse health effects when misused recreationally.
The Entourage Effect
The entourage effect is a phenomenon where cannabinoids and terpenes work together, enhancing the overall therapeutic impact. This synergy is a cornerstone of TKI’s approach to formulating blended products that maximize health outcomes.